| - GRCh37:
- Chr22:51065685
- GRCh38:
- Chr22:50627257
| ARSA | K125T, K39T | Metachromatic leukodystrophy | Pathogenic (Jul 27, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064623-51064624
- GRCh38:
- Chr22:50626195-50626196
| ARSA | R227fs, R313fs | Metachromatic leukodystrophy | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065326
- GRCh38:
- Chr22:50626898
| ARSA | A121D, A207D | Metachromatic leukodystrophy | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066101
- GRCh38:
- Chr22:50627673
| ARSA | G36E | Metachromatic leukodystrophy | Uncertain significance (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064412
- GRCh38:
- Chr22:50625984
| ARSA | | Metachromatic leukodystrophy | Uncertain significance (Aug 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063703
- GRCh38:
- Chr22:50625275
| ARSA | Q381P, Q467P | Metachromatic leukodystrophy | Uncertain significance (Sep 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064623
- GRCh38:
- Chr22:50626195
| ARSA | R227L, R313L | Metachromatic leukodystrophy | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065605
- GRCh38:
- Chr22:50627177
| ARSA | S152T, S66T | Metachromatic leukodystrophy | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066010
- GRCh38:
- Chr22:50627582
| ARSA | | Metachromatic leukodystrophy | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:50167881-51066207
| MAPK12, MAPK8IP2, PANX2, PIM3, MIOX, MLC1, MOV10L1, NCAPH2, ODF3B, ADM2, ALG12, ARSA, BRD1, CHKB, CPT1B, CRELD2, DENND6B, HDAC10, IL17REL, KLHDC7B, LMF2, MAPK11, PLXNB2, PPP6R2, SBF1, SCO2, SELENOO, SYCE3, TRABD, TTLL8, TUBGCP6, TYMP, ZBED4 | | Metachromatic leukodystrophy, not provided | Pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063573-51064511
| ARSA | | Metachromatic leukodystrophy | Pathogenic (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064466
- GRCh38:
- Chr22:50626038
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063674
- GRCh38:
- Chr22:50625246
| ARSA | S391C, S477C | Metachromatic leukodystrophy | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066019
- GRCh38:
- Chr22:50627591
| ARSA | | Metachromatic leukodystrophy | Likely benign (Sep 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065327
- GRCh38:
- Chr22:50626899
| ARSA | A121T, A207T | Metachromatic leukodystrophy | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064099
- GRCh38:
- Chr22:50625671
| ARSA | Q287P, Q373P | Metachromatic leukodystrophy, Inborn genetic diseases | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:51063851
- GRCh38:
- Chr22:50625423
| ARSA | A332T, A418T | Metachromatic leukodystrophy | Uncertain significance (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066183
- GRCh38:
- Chr22:50627755
| ARSA | L9I | Metachromatic leukodystrophy | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065499
- GRCh38:
- Chr22:50627071
| ARSA | | Metachromatic leukodystrophy | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065378
- GRCh38:
- Chr22:50626950
| ARSA | E104Q, E190Q | Metachromatic leukodystrophy | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063668
- GRCh38:
- Chr22:50625240
| ARSA | V393M, V479M | Metachromatic leukodystrophy | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064125
- GRCh38:
- Chr22:50625697
| ARSA | | Metachromatic leukodystrophy | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065613
- GRCh38:
- Chr22:50627185
| ARSA | I149T, I63T | Metachromatic leukodystrophy | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065758
- GRCh38:
- Chr22:50627330
| ARSA | G101C, G15C | Metachromatic leukodystrophy | Likely pathogenic (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065194
- GRCh38:
- Chr22:50626766
| ARSA | | Metachromatic leukodystrophy | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065073
- GRCh38:
- Chr22:50626645
| ARSA | I267T, I181T | Metachromatic leukodystrophy | Uncertain significance (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064419
- GRCh38:
- Chr22:50625991
| ARSA | P265L, P351L | Metachromatic leukodystrophy | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066198
- GRCh38:
- Chr22:50627770
| ARSA | G4R | Metachromatic leukodystrophy | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065053
- GRCh38:
- Chr22:50626625
| ARSA | E188K, E274K | Metachromatic leukodystrophy | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065582
- GRCh38:
- Chr22:50627154
| ARSA | | Metachromatic leukodystrophy | Likely benign (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063611
- GRCh38:
- Chr22:50625183
| ARSA | R412C, R498C | Metachromatic leukodystrophy | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065084
- GRCh38:
- Chr22:50626656
| ARSA | | Metachromatic leukodystrophy | Likely benign (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064583
- GRCh38:
- Chr22:50626155
| ARSA | | Metachromatic leukodystrophy | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064619
- GRCh38:
- Chr22:50626191
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065381
- GRCh38:
- Chr22:50626953
| ARSA | V103M, V189M | Inborn genetic diseases, Metachromatic leukodystrophy | Uncertain significance (May 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:51064725-51064726
- GRCh38:
- Chr22:50626297-50626298
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065448
- GRCh38:
- Chr22:50627020
| ARSA | | Metachromatic leukodystrophy | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065577
- GRCh38:
- Chr22:50627149
| ARSA | | Metachromatic leukodystrophy | Likely benign (May 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065576-51065577
- GRCh38:
- Chr22:50627148-50627149
| ARSA | | Metachromatic leukodystrophy | Likely benign (May 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065736
- GRCh38:
- Chr22:50627308
| ARSA | T108I, T22I | Metachromatic leukodystrophy | Uncertain significance (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065632
- GRCh38:
- Chr22:50627204
| ARSA | F57L, F143L | Metachromatic leukodystrophy | Pathogenic (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066092
- GRCh38:
- Chr22:50627664
| ARSA | G39D | Metachromatic leukodystrophy | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064564
- GRCh38:
- Chr22:50626136
| ARSA | | Metachromatic leukodystrophy | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064572
- GRCh38:
- Chr22:50626144
| ARSA | | Metachromatic leukodystrophy | Likely benign (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063880
- GRCh38:
- Chr22:50625452
| ARSA | S322T, S408T | Metachromatic leukodystrophy | Likely pathogenic (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063895
- GRCh38:
- Chr22:50625467
| ARSA | | Metachromatic leukodystrophy | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065002
- GRCh38:
- Chr22:50626574
| ARSA | | Metachromatic leukodystrophy | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064068
- GRCh38:
- Chr22:50625640
| ARSA | D297E, D383E | Metachromatic leukodystrophy | Uncertain significance (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063650
- GRCh38:
- Chr22:50625222
| ARSA | P399S, P485S | Metachromatic leukodystrophy | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064691
- GRCh38:
- Chr22:50626263
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063695
- GRCh38:
- Chr22:50625267
| ARSA | A384T, A470T | Metachromatic leukodystrophy | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063989
- GRCh38:
- Chr22:50625561
| ARSA | | Metachromatic leukodystrophy | Likely benign (Oct 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065108
- GRCh38:
- Chr22:50626680
| ARSA | E169D, E255D | Metachromatic leukodystrophy | Uncertain significance (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064588
- GRCh38:
- Chr22:50626160
| ARSA | A239T, A325T | Metachromatic leukodystrophy | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066170
- GRCh38:
- Chr22:50627742
| ARSA | L13Q | Metachromatic leukodystrophy | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065647
- GRCh38:
- Chr22:50627219
| ARSA | P52T, P138T | Metachromatic leukodystrophy | Pathogenic (Jan 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065623
- GRCh38:
- Chr22:50627195
| ARSA | F60L, F146L | Metachromatic leukodystrophy | Likely pathogenic (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064654
- GRCh38:
- Chr22:50626226
| ARSA | G217R, G303R | Metachromatic leukodystrophy | Pathogenic (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063824
- GRCh38:
- Chr22:50625396
| ARSA | P341S, P427S | not specified, Metachromatic leukodystrophy | Conflicting interpretations of pathogenicity (May 19, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:51065846
- GRCh38:
- Chr22:50627418
| ARSA | | Metachromatic leukodystrophy | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063809
- GRCh38:
- Chr22:50625381
| ARSA | D432N, D346N | Metachromatic leukodystrophy | Uncertain significance (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063615
- GRCh38:
- Chr22:50625187
| ARSA | | Metachromatic leukodystrophy | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065036
- GRCh38:
- Chr22:50626608
| ARSA | | Metachromatic leukodystrophy | Likely benign (Nov 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065828
- GRCh38:
- Chr22:50627400
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063806
- GRCh38:
- Chr22:50625378
| ARSA | | Metachromatic leukodystrophy | Likely benign (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065285-51065286
- GRCh38:
- Chr22:50626857-50626858
| ARSA | F135fs, F221fs | Metachromatic leukodystrophy | Pathogenic (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065376
- GRCh38:
- Chr22:50626948
| ARSA | | Metachromatic leukodystrophy | Likely benign (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065665
- GRCh38:
- Chr22:50627237
| ARSA | P46S, P132S | Metachromatic leukodystrophy | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065469
- GRCh38:
- Chr22:50627041
| ARSA | | Metachromatic leukodystrophy | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065673
- GRCh38:
- Chr22:50627245
| ARSA | G129E, G43E | Metachromatic leukodystrophy | Uncertain significance (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065103
- GRCh38:
- Chr22:50626675
| ARSA | D257V, D171V | Metachromatic leukodystrophy | Likely pathogenic (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066104
- GRCh38:
- Chr22:50627676
| ARSA | Y35F | Metachromatic leukodystrophy | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066032
- GRCh38:
- Chr22:50627604
| ARSA | L59P | Metachromatic leukodystrophy | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065795
- GRCh38:
- Chr22:50627367
| ARSA | | Metachromatic leukodystrophy | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064610
- GRCh38:
- Chr22:50626182
| ARSA | | Metachromatic leukodystrophy | Likely benign (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065180
- GRCh38:
- Chr22:50626752
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065464-51065484
- GRCh38:
- Chr22:50627036-50627056
| ARSA | | Metachromatic leukodystrophy | Pathogenic (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065462
- GRCh38:
- Chr22:50627034
| ARSA | T162A, T76A | Metachromatic leukodystrophy | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065372
- GRCh38:
- Chr22:50626944
| ARSA | Q106*, Q192* | Metachromatic leukodystrophy | Pathogenic (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065584
- GRCh38:
- Chr22:50627156
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065637
- GRCh38:
- Chr22:50627209
| ARSA | Q55fs, Q141fs | Metachromatic leukodystrophy | Pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065671
- GRCh38:
- Chr22:50627243
| ARSA | V130M, V44M | Metachromatic leukodystrophy | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064511-51064512
- GRCh38:
- Chr22:50626083-50626084
| ARSA | | Metachromatic leukodystrophy | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065288
- GRCh38:
- Chr22:50626860
| ARSA | P134T, P220T | Metachromatic leukodystrophy | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065388
- GRCh38:
- Chr22:50626960
| ARSA | N100K, N186K | Metachromatic leukodystrophy | Uncertain significance (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065050
- GRCh38:
- Chr22:50626622
| ARSA | E275K, E189K | Metachromatic leukodystrophy | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065266
- GRCh38:
- Chr22:50626838
| ARSA | S141F, S227F | Metachromatic leukodystrophy | Likely pathogenic (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065783
- GRCh38:
- Chr22:50627355
| ARSA | | Metachromatic leukodystrophy | Likely benign (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065415
- GRCh38:
- Chr22:50626987
| ARSA | | Metachromatic leukodystrophy | Likely benign (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063611
- GRCh38:
- Chr22:50625183
| ARSA | R412fs, R498fs | Metachromatic leukodystrophy | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063733
- GRCh38:
- Chr22:50625305
| ARSA | A371V, A457V | Metachromatic leukodystrophy | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065300
- GRCh38:
- Chr22:50626872
| ARSA | R130C, R216C | Inborn genetic diseases, Metachromatic leukodystrophy | Uncertain significance (Feb 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:51066097-51066098
- GRCh38:
- Chr22:50627669-50627670
| ARSA | | Metachromatic leukodystrophy | Pathogenic (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065751
- GRCh38:
- Chr22:50627323
| ARSA | P103R, P17R | Metachromatic leukodystrophy | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065461
- GRCh38:
- Chr22:50627033
| ARSA | T162S, T76S | Metachromatic leukodystrophy | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065795
- GRCh38:
- Chr22:50627367
| ARSA | | Metachromatic leukodystrophy | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51066039
- GRCh38:
- Chr22:50627611
| ARSA | G57R | Metachromatic leukodystrophy | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51063772-51063773
- GRCh38:
- Chr22:50625344-50625345
| ARSA | L444fs, L358fs | Metachromatic leukodystrophy | Pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51065050
- GRCh38:
- Chr22:50626622
| ARSA | E275Q, E189Q | Metachromatic leukodystrophy | Uncertain significance (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:51064441
- GRCh38:
- Chr22:50626013
| ARSA | A344P, A258P | Metachromatic leukodystrophy | Uncertain significance (Dec 25, 2021) | criteria provided, single submitter |